Rayner Receives Third FDA Approval in RayOne IOL Portfolio
Posted on 17/05/2021
New York, USA, May 17, 2021 – RayOne Spheric, a fully-preloaded monofocal IOL, has received FDA approval. This achievement marks Rayner’s third FDA approval in under three years within its expanding RayOne preloaded IOL portfolio. RayOne Spheric joins RayOne Aspheric (FDA approved December 2018) and RayOne EMV, a new non-diffractive IOL solution which achieved FDA
RayOne EMV IOL (Rayner) Receives FDA Approval
Posted on 26/03/2021
New York, USA, March 26, 2021 – RayOne EMV, a new fully preloaded non-diffractive IOL, has received FDA approval. RayOne EMV was developed in collaboration with world renowned surgeon Professor Graham Barrett, president of the Australasian Society of Cataract & Refractive Surgeons. “I collaborated with Rayner on bringing to market RayOne EMV, an exciting
Rayner Continues Growth in North America with Direct Presence in Canada
Posted on 21/01/2021
Worthing, UK – Following the recent approval of incorporation, Rayner is proud to announce its direct entry into the Canadian ophthalmology market. Led by Wade Allen, Director: Americas, Rayner Surgical Corp will now be offering the Rayner portfolio of IOLs and injectors directly to Canadian surgeons. Rayner Surgical Corp has recently had the RayOne Aspheric